Edition:
United Kingdom

People: CellaVision AB (CEVI.ST)

CEVI.ST on Stockholm Stock Exchange

331.00SEK
19 Jul 2019
Change (% chg)

-5.50kr (-1.63%)
Prev Close
336.50kr
Open
335.00kr
Day's High
341.00kr
Day's Low
326.50kr
Volume
34,838
Avg. Vol
38,612
52-wk High
357.50kr
52-wk Low
185.00kr

Fahraeus, Christer 

Mr. Christer Fahraeus has been Member of the Board of Directors of CellaVision AB since June 1998. Previously he was Chief Executive Officer and Member of the Board of the Company. He joined the Board in 1994. He is founder of the Company. His former positions include Chief Executive Officer of Anoto Group AB and Agellis Group AB. He is founder of Anoto Group AB, Precise Biometrics AB, Agellis Group AB and Flatfrog Laboratories AB, among others. He is Chief Executive Officer of EQL Pharma AB and Chairman of the Board of Longboat laboratoriesof, Respiratorius AB and Flatfrog Laboratories AB. He is also Member of the Boards of EQL Pharma AB, Lunds universitets innovationssystem AB, Faro Capital AB and Reccan AB. Mr. Fahraeus holds a Master of Science degree in Bioengineering and a Bachelor of Science degree in Mathematics from Lunds Universitet. He also holds a honoris causa Doctorate in Philosophy from Lunds Universitet.

Basic Compensation

Total Annual Compensation, SEK 200,000
Restricted Stock Award, SEK --
Long-Term Incentive Plans, SEK --
All Other, SEK --
Fiscal Year Total, SEK 200,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --